David Bredt - Insider Trading & Ownership

Location
C/O Rapport Therapeutics, 1325 Boylston St., Suite 401, Boston, MA
Summary
The estimated net worth of David Bredt is at least $10.2M dollars as of November 18, 2025. David Bredt is the Chief Scientific Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $10.2M.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of David Bredt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Scientific Officer $10.2M -$1.03M -9.17% Nov 17, 2025

Insider Transactions Reported by David Bredt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.